Literature DB >> 4854492

Studies on the peripheral mode of action of dihydroergotamine in human and canine veins.

E Müller-Schweinitzer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4854492     DOI: 10.1016/0014-2999(74)90150-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  12 in total

1.  The current status of low-dose heparin in the prophylaxis of thrombophlebitis and pulmonary embolism.

Authors:  V V Kakkar
Journal:  World J Surg       Date:  1978-01       Impact factor: 3.352

2.  Investigation of the venoconstrictor effect of 8' hydroxydihydroergotamine, the main metabolite of dihydroergotamine, in man.

Authors:  W H Aellig
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

3.  Pharmacological actions of the main metabolites of dihydroergotamine.

Authors:  E Müller-Schweinitzer
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

4.  A new technique for recording compliance of human hand veins.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1981-03       Impact factor: 4.335

5.  The effects of nitroglycerin on exercise-induced regional myocardial contractile dysfunction are not diminished by pretreatment with dihydroergotamine.

Authors:  W Schneider; G Krumpl; N Mayer; G Raberger
Journal:  Br J Pharmacol       Date:  1987-09       Impact factor: 8.739

6.  Venoconstrictor responses to dihydroergocristine and dihydroergotamine: evidence for the involvement of 5-HT1 like receptors.

Authors:  E Müller-Schweinitzer
Journal:  Cardiovasc Drugs Ther       Date:  1990-12       Impact factor: 3.727

7.  Actions of co-dergocrine mesylate and its components at vascular smooth muscle.

Authors:  E Müller-Schweinitzer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-02       Impact factor: 3.000

8.  Effects of dihydroergotamine (DHE) on blood flow and metabolism in the underperfused myocardium in anaesthetized dogs.

Authors:  R Seitelberger; W Schütz; G Raberger
Journal:  Basic Res Cardiol       Date:  1984 Jul-Aug       Impact factor: 17.165

9.  Alpha-adrenoceptors, 5-hydroxytryptamine receptors and the action of dihydroergotamine in human venous preparations obtained during saphenectomy procedures for varicose veins.

Authors:  E Müller-Schweinitzer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-10       Impact factor: 3.000

10.  Ergotamine abuse and extra-hepatic portal hypertension.

Authors:  P E Fisher; D B Silk; N Menzies-Gow; M Dingle
Journal:  Postgrad Med J       Date:  1985-05       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.